Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Maiden Pharmaceuticals

    Jump to

    • Maiden Pharma denies tampering with tests in probe of cough syrup deaths

      "I have never changed the sample," Maiden founder Naresh Kumar Goyal told Reuters. "There is no evidence and no proof against us. I have not given a bribe."

    • India probe into bribery claim in toxic syrup tests nears completion

      While the World Health Organization (WHO) linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in the African country last year, India's government says tests at an Indian government laboratory showed the syrups were not toxic.

    • Fresh trouble for tainted pharma firm linked with Gambia deaths in decade-old case

    • WHO awaits probe by Indian drug regulator to chart the fate of Marion Biotech

    • What can the inspection of select drugmaking units hope to achieve?

    • Drug standard watchdog inspects ‘suspicious’ manufacturing units across India

    • Maiden seeks to reopen plant after India government lab says cough syrups were safe

    • Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt

    • Will proposed drug database resolve lax monitoring of quality?

    • Gambian children deaths highlight deep rooted malaise in Indian pharma

    • WHO noncommittal on sharing cough syrup causality assessment report: Govt sources

    • Post-Gambia deaths, CDSCO and state regulators start testing cough syrups sold in market

    • Haryana regulator raises red flag over glaring lapses at Maiden Pharma plant

    • Exclusive | Early probe finds violation in drug manufacturing process by Maiden Pharma

    • How Maiden and other Indian pharma firms exploited WHO certification process

    • Maiden Pharma says medicines linked to Gambia child deaths not sold in India

    • Kerala halts sale of drugs made by Maiden Pharma under fire for children's death in Gambia

    • Moneycontrol Daily: Your Essential 7

    • Maiden Pharma’s factory wears a deserted look as its fate hangs in the balance

    • Govt must fix accountability: Anand Sharma on 'cough syrups-linked' deaths in Gambia

    • Why Indian regulators fail to prevent fatal lapses in drug manufacturing

    • Indian pharma company under fire for Gambia child deaths has a history of selling substandard drugs

    • Moneycontrol Selects: Top stories this evening

    • Cough syrup deaths: Govt says drugs not permitted for sale in India

    • India vows action if cough syrup proved to be behind Gambia deaths

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347